![](https://www.diabetesnews.com/wp-content/uploads/2014/05/Receiver-sensor-shadow-v2-150x150.png)
Updates on the European Approval to Launch the Freestyle Libre System, FDA “Tentative Approval” of BI/Lilly’s insulin glargine Basaglar and NIH $20 Million commitment for Pivotal Artificial Pancreas Studies.
Updates on the European Approval to Launch the Freestyle Libre System, FDA “Tentative Approval” of BI/Lilly’s insulin glargine Basaglar and NIH $20 Million commitment for Pivotal Artificial Pancreas Studies.